1 week Ago Lemon_tm/iStock via Getty Images Alcon ( ALC ) said on Wednesday it has acquired a majority interest in Aurion Biotech, a company into developing advanced cell therapies to treat eye diseases. Aurion will continue to operate independently, with full support from Alcon to advance its lead cell.
